Zimmer Biomet Holdings, Inc.

ZBH Healthcare Medical Devices

Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.

Revenue
+3.07%
EPS
−13.5%
Free cash flow
+29.8%
Total debt
−7.50%

Quarter to September 2026, against a year earlier

105.28 1.57 −1.47%
Market cap
$20.4B
P/E
26.9×
Fwd P/E
18.9×
Dividend yield
0.90%
F-score
6/9
Altman Z
2.38
Beneish M
−2.59
Dividend safety
72/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
68.03 13.37 0.00 26.65 0.00 64.57 115.71 24.72 23.74 25.19
Piotroski F-Score
5 6 5 7 3 7 5 8 6 6
P/S ratio
2.64 3.15 2.61 3.77 5.11 3.81 3.84 3.43 2.79 2.16
Altman Z-Score
1.65 2.01 1.95 2.61 2.50 2.54 2.97 3.01 2.86 2.38
Altman Z″-Score (non-manufacturers)
2.40 2.70 2.76 3.09 3.10 3.31 3.74 3.96 4.25 3.96
P/FCF ratio
18.40 22.56 15.83 37.14 61.75 26.57 30.60 28.94 27.41 16.53
Beneish M-Score
(2.59) (2.51) (3.07) (2.43) (2.57) (2.72) (2.62) (2.54) (2.59) (2.59)
P/Operating CF
32.32 60.99 54.56 71.14 105.64 77.00 109.25 43.06 42.37 34.41
Dividend Safety Score
— — — — — — — — — 72
P/B ratio
2.10 2.09 1.84 2.43 2.56 2.05 2.22 2.03 1.72 1.40
EV/Sales
4.03 4.38 3.67 4.73 6.30 4.79 4.61 4.15 3.53 3.00
EV/EBITDA
16.33 15.59 14.17 17.04 26.01 18.02 16.71 13.76 11.89 11.28
EV/FCF
28.02 31.39 22.24 46.51 76.21 33.41 36.70 35.05 34.67 22.96
Current Ratio
1.96 1.49 1.83 1.37 1.99 1.41 1.88 1.61 1.91 1.98
Net Debt/EBITDA
5.61 4.38 4.09 3.43 4.93 3.69 2.78 2.40 2.49 3.16
Debt/Equity
1.16 0.86 0.79 0.66 0.67 0.56 0.47 0.46 0.50 0.59
ROE
3.13% 16.95% (3.30%) 9.56% (1.13%) 3.23% 1.87% 8.35% 7.24% 5.60%
ROA
1.14% 6.88% (1.51%) 4.64% (0.57%) 1.68% 1.04% 4.81% 4.22% 3.17%
ROIC
2.53% 2.34% 0.11% 3.56% 0.27% 2.78% 2.51% 4.48% 4.43% 3.50%
Return on Tangible Assets
7.08% 51.33% (9.43%) 33.68% (3.04%) 12.34% 5.87% 26.86% 21.17% 14.87%
Average Days of Receivables
76.37 72.23 58.70 62.37 86.53 67.34 72.66 71.20 70.38 75.58
Earnings Yield
1.47% 7.48% (1.82%) 3.75% (0.45%) 1.55% 0.86% 4.04% 4.21% 3.97%
Free Cash Flow Yield
5.44% 4.43% 6.32% 2.69% 1.62% 3.76% 3.27% 3.46% 3.65% 6.05%
Free Cash Flow per Share
5.51 5.40 6.43 4.22 3.40 4.69 4.20 4.19 4.44 5.66
Book value per Share
48.35 58.13 55.41 60.42 58.93 60.72 57.38 59.84 61.43 64.17
Free Cash Flow
1,102.00 1,089.30 1,308.40 865.20 704.30 978.70 880.30 875.40 902.30 1,119.70
EV/EBIT
37.61 42.77 861.01 33.16 464.67 37.99 45.96 24.02 21.10 22.52
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026